# SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients

> **NCT06029179** · NA · COMPLETED · sponsor: **Alexandria University** · enrollment: 120 (actual)

## Conditions studied

- Hyperkalemia

## Interventions

- **DRUG:** sodium zirconium cyclosilicate (SZC)
- **DRUG:** sodium polystyrene sulfonate

## Key facts

- **NCT ID:** NCT06029179
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-15
- **Primary completion:** 2024-10-15
- **Final completion:** 2024-12-15
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06029179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06029179, "SZC Versus SPS for Treatment of Hyperkalemia in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06029179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*